Article
Rock inhibitors target <i>SRSF2</i> leukemia by disrupting cell mitosis and nuclear morphology
2022-02-17
Abstract excerpt
Spliceosome machinery mutations are common early mutations in myeloid malignancies, however effective targeted therapies against them are still lacking. In the current study, we used an in vitro high-throughput drug screen among four different isogenic cell lines and identified ROCK inhibitors (ROCKi) as selective inhibitors of SRSF2 mutants. ROCKi targeted SRSF2 Mut primary human samples in a xenografts model...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 46d94059-f14a-55ef-9b0a-c043eaa985e3
- DOI
- 10.1101/2022.02.15.479934
